Prevalence and determinants of Chlamydia trachomatis infections in women from Bogota, Colombia

被引:30
作者
Molano, M
Weiderpass, E
Posso, H
Morré, SA
Ronderos, M
Franceschi, S
Arslan, A
Meijer, CJLM
Muñoz, N
van den Brule, AJC
机构
[1] Int Agcy Res Canc, Unit Field & Intervent Studies, F-69372 Lyon 08, France
[2] Vrije Univ Amsterdam, Med Ctr, Dept Pathol, Amsterdam, Netherlands
[3] Inst Nacl Cancerol, Div Invest, Bogota, Colombia
[4] Free Univ Amsterdam, Fac Med, Med Ctr, Immunogenet Lab, Amsterdam, Netherlands
关键词
D O I
10.1136/sti.79.6.474
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: Chlamydia trachomatis infection in the cervix and uterus has been hypothesised to be a cofactor for cervical cancer. We performed a cross sectional study in Bogota, Colombia, where cervical cancer rates are high, to determine the prevalence and determinants of C trachomatis infection, and in particular its association with human papillomavirus ( HPV). Methods: 1829 low income sexually active women were interviewed and tested for C trachomatis, using an endogenous plasmid PCR- EIA, and for 37 HPV types, using a general primer GP5+/ 6+ mediated PCR-EIA. Results: The overall prevalence of C trachomatis was 5.0%, and it did not differ substantially between women with normal ( 5.0%) and those with abnormal ( 5.2%) cervical cytology. Women infected with any HPV type ( 15.1%) had a slightly increased risk of being simultaneously infected with C trachomatis ( adjusted OR 1.3, 95% CI: 0.8 to 2.4). This association was stronger when multiple HPV infections ( adjusted OR 2.5, 95% CI: 1.1 to 5.9) were present. No other lifestyle or reproductive characteristics were clearly associated with risk of C trachomatis infection. Conclusions: HPV infected women, particularly women with multiple HPV infections, are at increased risk of being infected with C trachomatis.
引用
收藏
页码:474 / 478
页数:5
相关论文
共 46 条
[1]   Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma [J].
Anttila, T ;
Saikku, P ;
Koskela, P ;
Bloigu, A ;
Dillner, J ;
Ikäheimo, I ;
Jellum, E ;
Lehtinen, M ;
Lenner, P ;
Hakulinen, T ;
Närvänen, A ;
Pukkala, E ;
Thoresen, S ;
Youngman, L ;
Paavonen, J .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (01) :47-51
[2]  
BAGSHAW SN, 1987, NEW ZEAL MED J, V100, P401
[3]   Risk factors of invasive cervical cancer in Mali [J].
Bayo, S ;
Bosch, FX ;
de Sanjosé, S ;
Muñoz, N ;
Combita, AL ;
Coursaget, P ;
Diaz, M ;
Dolo, A ;
van den Brule, AJC ;
Meijer, CJM .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2002, 31 (01) :202-209
[4]  
BOSCH FX, 1993, CANCER EPIDEM BIOMAR, V2, P415
[5]  
Chaouki N, 1998, INT J CANCER, V75, P546, DOI 10.1002/(SICI)1097-0215(19980209)75:4&lt
[6]  
546::AID-IJC9&gt
[7]  
3.0.CO
[8]  
2-T
[9]   Risk factors for cervical cancer in Thailand:: A case-control study [J].
Chichareon, S ;
Herrero, R ;
Muñoz, N ;
Bosch, FX ;
Jacobs, MV ;
Deacon, J ;
Santamaria, M ;
Chongsuvivatwong, V ;
Meijer, CJLM ;
Walboomers, JMM .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (01) :50-57
[10]  
COTTINGHAM J, 1992, GENITOURIN MED, V68, P209